Trial Profile
Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2005
Price :
$35
*
At a glance
- Drugs AZD 5438 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 26 Aug 2005 New trial record.